title: Decreased Tc-99m MDP uptake in myelonecrosis.
authors.affiliation: Department of Nuclear Medicine, Inonu University, Medical Faculty, Malatya, Turkey. ekekilli@inonu.edu.tr
authors.forename: Ersoy
authors.initials: E
authors.lastname: Kekilli
authors.forename: Cengiz
authors.initials: C
authors.lastname: Yagmur
authors.forename: Emin
authors.initials: E
authors.lastname: Kaya
authors.forename: Irfan
authors.initials: I
authors.lastname: Kuku
authors.forename: Kadir
authors.initials: K
authors.lastname: Ertem
authors.forename: Ismet
authors.initials: I
authors.lastname: Aydogdu
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001855:Bone Marrow Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology; D004008:Diclofenac / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009336:Necrosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013669:Technetium Tc 99m Medronate / Q000493:pharmacokinetics
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019275:Radiopharmaceuticals; D004008:Diclofenac; D013669:Technetium Tc 99m Medronate